Erlocip 150mg
Erlocip-100/150mg containing the active ingredient erlotinib is considered a tyrosine kinase inhibitor type of medication. The medication works by interfering with the protein epidermal growth factor to prevent it from activating enzymes certain cancer cells require to grow and multiply. The tablets can be used along with other medications or other types of cancer treatment to treat nonsmall cell lung cancer and pancreatic cancer that has spread to nearby tissues or to other parts of the body.
Compositions :
|